User profiles for Christopher H. Goss
Christopher H. GossProfessor of Medicine and Pediatrics Verified email at uw.edu Cited by 17920 |
The future of cystic fibrosis care: a global perspective
…, R Cosgriff, I Eichler, I Fajac, CH Goss… - The Lancet …, 2020 - thelancet.com
The past six decades have seen remarkable improvements in health outcomes for people
with cystic fibrosis, which was once a fatal disease of infants and young children. However, …
with cystic fibrosis, which was once a fatal disease of infants and young children. However, …
Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations
The natural history of cystic fibrosis lung disease is one of chronic progression with
intermittent episodes of acute worsening of symptoms frequently called acute pulmonary …
intermittent episodes of acute worsening of symptoms frequently called acute pulmonary …
Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health
…, BP O'Sullivan, KA Robinson, CH Goss… - American journal of …, 2007 - atsjournals.org
Rationale: Cystic fibrosis is a recessive genetic disease characterized by dehydration of the
airway surface liquid and impaired mucociliary clearance. As a result, individuals with the …
airway surface liquid and impaired mucociliary clearance. As a result, individuals with the …
Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation
…, LR Hoffman, GJ Redding, CH Goss - American journal of …, 2010 - atsjournals.org
Rationale: Patients with cystic fibrosis periodically experience pulmonary exacerbations.
Previous studies have noted that some patients' lung function (FEV 1 ) does not improve with …
Previous studies have noted that some patients' lung function (FEV 1 ) does not improve with …
Exacerbations in cystic fibrosis· 1: epidemiology and pathogenesis
CH Goss, JL Burns - Thorax, 2007 - thorax.bmj.com
With the improving survival of patients with cystic fibrosis (CF), the clinical spectrum of this
complex multisystem disease continues to evolve. One of the most important clinical events for …
complex multisystem disease continues to evolve. One of the most important clinical events for …
[HTML][HTML] Hospital volume and the outcomes of mechanical ventilation
Background An increased volume of patients is associated with improved survival in
numerous high-risk medical and surgical conditions. The relationship between the number of …
numerous high-risk medical and surgical conditions. The relationship between the number of …
Incidence of acute lung injury in the United States
CH Goss, RG Brower, LD Hudson… - Critical care …, 2003 - journals.lww.com
Objective Recent estimates of acute respiratory distress syndrome (ARDS) incidence have
varied from 1.3 to 22 per 100,000 person years (10 5 person· years); the incidence of acute …
varied from 1.3 to 22 per 100,000 person years (10 5 person· years); the incidence of acute …
Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry
Background: Advances in treatments for cystic fibrosis (CF) continue to extend survival. An
updated estimate of survival is needed for better prognostication and to anticipate evolving …
updated estimate of survival is needed for better prognostication and to anticipate evolving …
Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial
Context Azithromycin is recommended as therapy for cystic fibrosis (CF) patients with chronic
Pseudomonas aeruginosa infection, but there has not been sufficient evidence to support …
Pseudomonas aeruginosa infection, but there has not been sufficient evidence to support …
Respiratory Outbreak of Mycobacterium abscessus Subspecies massiliense in a Lung Transplant and Cystic Fibrosis Center
…, P Pottinger, E Whimbey, CH Goss… - American journal of …, 2012 - atsjournals.org
There has been no published report of direct or indirect patientto-patient respiratory spread
of nontuberculous mycobacteria (NTM)(1–5). We report an outbreak of Mycobacterium …
of nontuberculous mycobacteria (NTM)(1–5). We report an outbreak of Mycobacterium …